Immunogenicity of Vibrio cholerae O1 toxin-coregulated pili in experimental and clinical cholera - PubMed (original) (raw)
Immunogenicity of Vibrio cholerae O1 toxin-coregulated pili in experimental and clinical cholera
R H Hall et al. Infect Immun. 1991 Jul.
Abstract
A functional tcpA gene, encoding the major subunit of toxin-coregulated pili (TCP), is necessary for Vibrio cholerae O1 Ogawa strain 395 to colonize the human intestine and confer protective immunity to virulent challenge. The immunogenicity of TCP and other antigens in experimental and naturally acquired cholera was determined. Seroconversion to cholera toxin (CT), whole cell preparations, and to Ogawa lipopolysaccharide but not to purified native TCP or to a TcpA mimiotope was found in volunteers. Local intestinal secretory immunoglobulin A from volunteers showed conversions to cholera toxin and lipopolysaccharide but not to TCP. Cholera patients in Indonesia showed a seroconversion rate to TCP of 3 of 6 and a seroconversion to a TcpA mimiotope of 1 of 6. Volunteer and patient sera showed similar vibriocidal seroconversions when assayed against either TCP-positive and TCP-negative V. cholerae O1 strains, suggesting that TCP do not contribute demonstrably to the vibriocidal antigen. We conclude that although seroconversion to TCP can occur in naturally acquired cholera, solid long-term protection can be engendered in the absence of a detectable anti-TCP immune response.
Similar articles
- A Vibrio cholerae classical TcpA amino acid sequence induces protective antibody that binds an area hypothesized to be important for toxin-coregulated pilus structure.
Taylor RK, Kirn TJ, Meeks MD, Wade TK, Wade WF. Taylor RK, et al. Infect Immun. 2004 Oct;72(10):6050-60. doi: 10.1128/IAI.72.10.6050-6060.2004. Infect Immun. 2004. PMID: 15385509 Free PMC article. - Pathogenic and vaccine significance of toxin-coregulated pili of Vibrio cholerae E1 Tor.
Attridge SR, Voss E, Manning PA. Attridge SR, et al. J Biotechnol. 1999 Aug 20;73(2-3):109-17. doi: 10.1016/s0168-1656(99)00114-5. J Biotechnol. 1999. PMID: 10486921 Review. - Enzyme-linked immunosorbent assay for determination of antibodies to Vibrio cholerae toxin-coregulated pili.
Osek J, Jonson G, Svennerholm AM, Holmgren J. Osek J, et al. APMIS. 1992 Nov;100(11):1027-32. doi: 10.1111/j.1699-0463.1992.tb04036.x. APMIS. 1992. PMID: 1361754 - In vitro production of toxin-coregulated pili by Vibrio cholerae El Tor.
Voss E, Attridge SR. Voss E, et al. Microb Pathog. 1993 Oct;15(4):255-68. doi: 10.1006/mpat.1993.1076. Microb Pathog. 1993. PMID: 7906005 - Significance of toxin-coregulated pili as protective antigens of Vibrio cholerae in the infant mouse model.
Sharma DP, Thomas C, Hall RH, Levine MM, Attridge SR. Sharma DP, et al. Vaccine. 1989 Oct;7(5):451-6. doi: 10.1016/0264-410x(89)90161-8. Vaccine. 1989. PMID: 2573216
Cited by
- Human Challenge Studies for Cholera.
Cohen MB. Cohen MB. Curr Top Microbiol Immunol. 2024;445:177-188. doi: 10.1007/82_2022_258. Curr Top Microbiol Immunol. 2024. PMID: 35377003 Review. - The major subunit of the toxin-coregulated pilus TcpA induces mucosal and systemic immunoglobulin A immune responses in patients with cholera caused by Vibrio cholerae O1 and O139.
Asaduzzaman M, Ryan ET, John M, Hang L, Khan AI, Faruque AS, Taylor RK, Calderwood SB, Qadri F. Asaduzzaman M, et al. Infect Immun. 2004 Aug;72(8):4448-54. doi: 10.1128/IAI.72.8.4448-4454.2004. Infect Immun. 2004. PMID: 15271902 Free PMC article. - The maltose regulon of Vibrio cholerae affects production and secretion of virulence factors.
Lång H, Jonson G, Holmgren J, Palva ET. Lång H, et al. Infect Immun. 1994 Nov;62(11):4781-8. doi: 10.1128/iai.62.11.4781-4788.1994. Infect Immun. 1994. PMID: 7927755 Free PMC article. - Recombinant toxin-coregulated pilus A (TcpA) as a candidate subunit cholera vaccine.
Kiaie S, Abtahi H, Mosayebi G, Alikhani M, Pakzad I. Kiaie S, et al. Iran J Microbiol. 2014 Apr;6(2):68-73. Iran J Microbiol. 2014. PMID: 25705354 Free PMC article. - The Live Attenuated Cholera Vaccine CVD 103-HgR Primes Responses to the Toxin-Coregulated Pilus Antigen TcpA in Subjects Challenged with Wild-Type Vibrio cholerae.
Mayo-Smith LM, Simon JK, Chen WH, Haney D, Lock M, Lyon CE, Calderwood SB, Kirkpatrick BD, Cohen M, Levine MM, Gurwith M, Harris JB. Mayo-Smith LM, et al. Clin Vaccine Immunol. 2017 Jan 5;24(1):e00470-16. doi: 10.1128/CVI.00470-16. Print 2017 Jan. Clin Vaccine Immunol. 2017. PMID: 27847368 Free PMC article. Clinical Trial.
References
- Infect Immun. 1991 Jan;59(1):114-8 - PubMed
- Bull World Health Organ. 1969;40(2):187-97 - PubMed
- Infect Immun. 1987 May;55(5):1116-20 - PubMed
- J Clin Microbiol. 1985 Feb;21(2):174-9 - PubMed
- Proc Natl Acad Sci U S A. 1987 May;84(9):2833-7 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical